Allurion Technologies, Inc. (NYSE:ALUR) Short Interest Down 19.1% in December

Allurion Technologies, Inc. (NYSE:ALUR) saw a large decrease in short interest in December. As of December 15th, there was short interest totaling 444,734 shares, a decrease of 19.1% from the November 30th total of 549,490 shares. Based on an average daily volume of 57,957 shares, the short-interest ratio is currently 7.7 days. Approximately 5.2% of the company’s shares are short sold. Approximately 5.2% of the company’s shares are short sold. Based on an average daily volume of 57,957 shares, the short-interest ratio is currently 7.7 days.

Allurion Technologies Price Performance

ALUR traded down $0.05 during trading on Wednesday, hitting $1.22. 73,644 shares of the stock traded hands, compared to its average volume of 50,895. The firm has a market capitalization of $11.25 million, a P/E ratio of -0.12 and a beta of -0.45. Allurion Technologies has a 12-month low of $1.02 and a 12-month high of $16.81. The firm has a 50-day moving average of $1.55 and a 200 day moving average of $2.10.

Allurion Technologies (NYSE:ALUR) last issued its quarterly earnings data on Wednesday, November 12th. The company reported ($1.18) EPS for the quarter, beating the consensus estimate of ($2.45) by $1.27. The firm had revenue of $2.66 million for the quarter, compared to the consensus estimate of $2.05 million. As a group, equities analysts predict that Allurion Technologies will post -9.96 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ALUR has been the subject of several recent research reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Allurion Technologies in a research note on Wednesday, October 8th. Chardan Capital reiterated a “neutral” rating on shares of Allurion Technologies in a report on Thursday, November 20th. One analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Allurion Technologies has a consensus rating of “Hold” and an average target price of $9.25.

Institutional Investors Weigh In On Allurion Technologies

A hedge fund recently raised its stake in Allurion Technologies stock. XTX Topco Ltd grew its holdings in shares of Allurion Technologies, Inc. (NYSE:ALUR) by 43.2% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 18,670 shares of the company’s stock after buying an additional 5,633 shares during the period. XTX Topco Ltd owned 0.25% of Allurion Technologies worth $45,000 as of its most recent SEC filing. Institutional investors and hedge funds own 21.39% of the company’s stock.

About Allurion Technologies

Allurion Technologies is a medical technology company specializing in non-surgical weight-loss solutions. The company’s flagship product, the Allurion Gastric Balloon, is a swallowable, fluid-filled device designed to promote weight loss by creating a sense of fullness in the stomach. Unlike traditional intragastric balloons, the Allurion device does not require endoscopic insertion or removal, as it self-deflates and is naturally expelled after treatment, simplifying the patient experience and reducing clinical resource requirements.

In addition to its gastric balloon, Allurion has developed a comprehensive digital health platform that integrates wireless tracking devices, a mobile application, and remote coaching to support patients throughout their weight-loss journey.